Hims & Hers Health (HIMS) News Today

$13.81
+0.07 (+0.51%)
(As of 05/15/2024 ET)
Hims & Hers Health, Inc. (NYSE:HIMS) Insider Soleil Boughton Sells 2,503 Shares
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Soleil Boughton sold 2,503 shares of Hims & Hers Health stock in a transaction on Monday, May 13th. The stock was sold at an average price of $12.33, for a total transaction of $30,861.99. Following the sale, the insider now directly owns 159,357 shares in the company, valued at approximately $1,964,871.81. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $130,000.00 in Stock
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Patrick Harrison Carroll sold 10,000 shares of the business's stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $13.00, for a total transaction of $130,000.00. Following the sale, the insider now directly owns 173,880 shares in the company, valued at approximately $2,260,440. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
3 Stocks That Suddenly Drew in Options Traders
Options are complicated and not for the faint of heart. While some investors may use them to take on irresponsible leverage levels on their minor positions, others could use them to express their predictions on a particular stock.
3 Stocks That Suddenly Drew in Options Traders (HIMS)
Three discounted stocks caught the attention of call option buyers last week, and they have Wall Street analysts to back them through double-digit upside.
Is Hims & Hers Health Stock a Buy?
Hims & Hers Health, Inc. (NYSE:HIMS) Forecasted to Earn Q4 2024 Earnings of $0.03 Per Share
Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) - Equities researchers at Leerink Partnrs cut their Q4 2024 earnings estimates for Hims & Hers Health in a research note issued to investors on Tuesday, May 7th. Leerink Partnrs analyst M. Cherny now expects that the company will post earnings of
10 Solid Reasons To Buy Hims & Hers Stock
Hims & Hers Health (NYSE:HIMS) PT Raised to $16.00
Analysts Offer Predictions for Hims & Hers Health, Inc.'s Q2 2024 Earnings (NYSE:HIMS)
Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) - Seaport Res Ptn lifted their Q2 2024 earnings per share estimates for shares of Hims & Hers Health in a report issued on Monday, May 6th. Seaport Res Ptn analyst A. Kessler now anticipates that the company will post earnings per share of $0.05
Deutsche Bank Aktiengesellschaft Boosts Hims & Hers Health (NYSE:HIMS) Price Target to $16.00
Deutsche Bank Aktiengesellschaft boosted their price target on shares of Hims & Hers Health from $14.00 to $16.00 and gave the company a "hold" rating in a report on Tuesday.
Hims & Hers Health Target of Unusually Large Options Trading (NYSE:HIMS)
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) was the recipient of some unusual options trading on Tuesday. Investors acquired 28,871 call options on the stock. This represents an increase of 249% compared to the average volume of 8,272 call options.
Hims & Hers Health (NYSE:HIMS) Sees Unusually-High Trading Volume Following Strong Earnings
Hims & Hers Health (NYSE:HIMS) Sees Strong Trading Volume After Strong Earnings
Hims & Hers Health Stock Could Become a Wealth Compounder
Shares of Hims & Hers Health Inc. NYSE: HIMS are jumping by as much as 15.5% after the company released its first quarter 2024 earnings results. This quarter is arguably the most important quarter as it sets the tone for the rest of the year in any stock.
Hims & Hers Health Stock Could Become a Wealth Compounder (HIMS)
Hims & Hers stock could give investors the best of both stability and double-digit upside through EPS projections and price targets, especially after 1Q24
Hims & Hers Health (NYSE:HIMS) Posts Earnings Results, Beats Expectations By $0.03 EPS
Hims & Hers Health (NYSE:HIMS - Get Free Report) posted its quarterly earnings data on Monday. The company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of $0.02 by $0.03. Hims & Hers Health had a negative net margin of 2.70% and a negative return on equity of 7.21%. The company had revenue of $278.20 million during the quarter, compared to the consensus estimate of $270.37 million. During the same quarter in the prior year, the company posted ($0.05) EPS. The company's quarterly revenue was up 45.8% compared to the same quarter last year.
Hims & Hers Health (NYSE:HIMS) Shares Gap Up to $11.26
Hims & Hers Health (NYSE:HIMS) Shares Gap Up to $11.26
Hims & Hers Health: An Unforced Error
Here's what to expect from Hims Hers Health A's earnings report
Get Hims & Hers Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter.

Top 5 AI Stocks to Buy for 2024 (Ad)

5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

7 Must-Buy Stocks Under $20

HIMS Media Mentions By Week

HIMS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HIMS
News Sentiment

0.46

0.55

Average
Medical
News Sentiment

HIMS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HIMS Articles
This Week

26

7

HIMS Articles
Average Week

Get Hims & Hers Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:HIMS) was last updated on 5/16/2024 by MarketBeat.com Staff

From Our Partners